54 results on '"Lisman, T."'
Search Results
2. Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen
3. Balance between von Willebrand factor and ADAMTS13 following major partial hepatectomy
4. Balance between von Willebrand factor and ADAMTS13 following major partial hepatectomy
5. Ex vivo addition of fibrinogen concentrate improves the fibrin network structure in plasma samples taken during liver transplantation
6. Decreased plasma levels of activated factor VII in patients with deep vein thrombosis
7. Development of a Hyperactive Primary Hemostatic System During Off-Pump Lung Transplantation Resulting From an Unbalance Between von Willebrand Factor and Its Cleaving Protease ADAMTS13
8. Prothrombotic properties of fibrin clots in patients with non-alcoholic fatty liver disease: OR435
9. Fibrinogen concentrate improves fibrin network structure during orthotopic liver transplantation: OR070
10. Platelets and fibrin in progression of liver disease: friends or foes?
11. Hypercoagulability following major partial liver resection - detected by thrombomodulin-modified thrombin generation testing
12. No increased systemic fibrinolysis in women with heavy menstrual bleeding
13. Injury of Peribiliary Glands and Vascular Plexus Before Liver Transplantation Predicts Formation of Non-Anastomotic Biliary Strictures.: Abstract# C1651
14. Criteria for Viability Assessment of Discarded Human Donor Livers During Ex-Vivo Normothermic Machine Perfusion.: Abstract# C1665
15. Injury to Peribiliary Glands and Vascular Plexus Before Liver Transplantation Predicts Formation of Non-Anastomotic Biliary Strictures.: Abstract# 2117
16. Increased mortality in systemic inflammatory response syndrome patients with high levels of coagulation factor VIIa
17. In vitro effects of proteases in human pancreatic juice on stability of liquid and carrier-bound fibrin sealants
18. No increased fibrinolysis in women with menorrhagia: PB 4.65–4
19. Platelet uptake of recombinant factor VIIa takes place in vivo but does not prolong its circulating half-life: PB 3.58–1
20. Proteases in human pancreatic juice degrade both liquid and carrier-bound fibrin sealants in vitro: PB 2.57–2
21. An unbalance between von Willebrand Factor and its cleaving protease ADAMTS13 in acute liver failure: implications for hemostasis and correlations with clinical outcome: PB 2.33–5
22. Increased anticoagulant response to drugs targeting thrombin, but not to drugs targeting FXa, in plasma from patients with cirrhosis: PB 1.46–5
23. The mechanism of action of prophylactic administration of recombinant factor VIIa may be explained by the presence of hemostatically active FVIIa in plasma throughout the time frame of prophylaxis: PB 1.38–1
24. Increased mortality in SIRS patients with low levels of zymogen and high levels of activated coagulation factor VII: PA 2.15–1
25. Chemotherapy-induced hypercoagulability and biomarkers for prediction of thromboembolic events in patients with metastatic testicular cancer: OC 04.4
26. Ex vivo Normothermic Machine Perfusion and Viability Testing of Discarded Human Donor Livers
27. The circulating platelet count is not dictated by the liver, but may be determined in part by the bone marrow: analyses from human liver and stem cell transplantations
28. Early hepatic regeneration index and completeness of regeneration at 6 months after partial hepatectomy
29. Intact thrombin generation and decreased fibrinolytic capacity in patients with acute liver injury or acute liver failure
30. Plasma levels of Midkine (neurite growth-promoting factor 2) are not associated with plasma fibrinolytic potential or risk of venous thrombosis
31. Activation of hemostasis in brain dead organ donors: an observational study
32. TAFI deficiency accelerates liver damage in murine models of chronic and acute liver failure: O-WE-047
33. Genome scan of clot lysis time and its association with thrombosis in a protein C-deficient kindred
34. Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1: O10A-4
35. Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in men: O9A-7
36. Intact thrombomodulin-mediated regulation of fibrinolysis during and after liver transplantation, despite a profoundly defective thrombomodulinmediated regulation of coagulation: O2A-5
37. Intact thrombomodulin-mediated regulation of fibrinolysis during and after liver transplantation, despite a profoundly defective thrombomodulin-mediated regulation of coagulation
38. Reporting prothrombin time results as international normalized ratios for patients with chronic liver disease
39. Hypofibrinolysis as a risk factor for recurrent venous thrombosis; results of the LETS follow-up study
40. Activation of Coagulation by Living Donor Kidney Transplants Early After Reperfusion
41. Staphylococcal superantigen-like 5 activates platelets and supports platelet adhesion under flow conditions, which involves glycoprotein Ibα and αIIbβ3
42. Plasma levels of fibrinolytic proteins and the risk of venous thrombosis: OC-WE-016
43. Hypofibrinolysis as a risk factor for thrombosis and linkage analysis of clot lysis time in a protein C deficient kindred: OC-TU-001
44. Development of a Severe von Willebrand Factor/ADAMTS13 Dysbalance During Orthotopic Liver Transplantation
45. Hypofibrinolysis as risk factor for arterial thrombosis: O12–03
46. A mechanism to safeguard platelet adhesion under high-shear flow: von Willebrand factor–glycoprotein Ib and integrin α2β1–collagen interactions make complementary, collagen-type-specific contributions to adhesion: a rebuttal
47. Platelet adhesion to dimeric β2-glycoprotein I under conditions of flow is mediated by at least two receptors: glycoprotein Ibα and apolipoprotein E receptor 2′
48. No evidence for an intrinsic platelet defect in patients with liver cirrhosis – studies under flow conditions
49. Hemostasis in chronic liver disease
50. Hemostasis in chronic liver disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.